The findings of this study suggest that VRK2 activates the transcription of NF-κB by phosphorylating IKKβ, thereby promoting the growth of pancreatic cancer cells and enhancing their tumorigenic ability in vivo (Fig. 8). The gene discussed is NFKB1; the disease is pancreatic neoplasm.